A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Rocky Mountain Regional VA Medical Center

Study ID

Protocol Number: 20-2294

More information available at ClinicalTrials.gov: NCT03539744

Categories

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers